For patients in the UK who are seeking effective, evidence-based weight management options, the following treatments are currently available and approved: Semaglutide 2.4 mg (Wegovy): A GLP-1 receptor agonist with MHRA approval for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
This consultation helps establish whether GLP-1 treatment is an appropriate option for you
This ongoing medical supervision is a key component of our GLP-1 weight loss program
Unlike other GHRPs, in clinical trials, Ipamorelin has demonstrated a more selective action, meaning it targets the bodys natural growth hormone production specifically, without causing unwanted side effects such as hunger or cortisol spikes in stress hormones
For example, shifting ratios of anti-inflammatory versus anti-fibrotic payloads may be necessary as MASLD progresses from steatosis to fibrosis
Blood chemistry studies is a procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body
